Page 9 - Pharma Industry

Aurobindo Pharma's debt pain recedes after calling off deal with Sandoz

Aurobindo was scheduled to acquire the portfolio with an upfront purchase price of $900 million in cash

Aurobindo terminates $900-million Sandoz product acquistion deal

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

India may soon ease some drug export curbs under US pressure: Report

Imports from India accounted for 24% of medicines and 31% of medicine ingredients to the United States in 2018, according to the US Food and Drug Administration

Pharma group seeks relaxation of export restrictions for committed orders

Bhaskar explained that some of the orders for institutional supplies mandate the supply of all items committed in their contracts.

Coronavirus impact: Firms stare at prospect of airlifting raw materials

Pharma industry officials said the aerial route was the best option available to companies right now, given the congestion at Chinese ports.

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

Indian pharma industry needs to adopt digital technologies, says EY report

India is the largest provider of generic drugs globally, fulfilling about 40 per cent of the generics demand in the US and roughly 25 per cent of all medicines in UK

Pharma industry poised to beat FY19 exports despite strict US regulations

April-December exports rise 11.5%; estimates peg FY20 numbers at $22 billion

Pharma companies can draw $30 bn revenue from US market by tapping 10 drugs

Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports

Tipping point: Should you bet on the revival of pharmaceutical funds?

Whenever the domestic economy is not doing well, smart money shifts to export-oriented sectors like pharma

Pharma industry considering 'ethics inspectors' to ensure better compliance

Pharma players to meet DoP to discuss suggestions around implementing ethical marketing practices code

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

In a booster dose, pharma industry gets 'green' signal in New Year

Drug makers allowed to tweak product mix or quantity without fresh environment clearance until effluent load is same

Pharma firms plan awareness drive to battle cancer scare in antacid

Indian companies have also been hit in their global business.

Pharma industry needs to develop entire value chain: Dr Reddy's G V Prasad

According to Prasad, the relevance of Indian pharma sector as a provider of affordable alternative to the world remains intact

China opens public hospitals for Dr Reddy's Laboratories generic drugs

First Indian firm to get contract for supplying generic schizophrenia drug to public hospitals there

Unichem gets USFDA approval for high blood pressure drug Chlorthalidone

Unichem said the product will be commercialised from its Ghaziabad plant

Natco Pharma's API facility near Hyderabad gets 6 USFDA observations

The company said that key points of the observations in Form 483 are the supplier and service provider agreements to be made more robust

Aurobindo to Jubilant Life Sciences, drug makers face USFDA heat

Some of the inspections have not yet received a final classification, which raises the potential for OAIs

Bulk drug exports rise as Indian makers cash in on China's regulatory woes

Iran emerged as a major destination in FY19 with 68% growth after registering negative growth in FY17 and FY18